Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Published in Dermatology

Journal Scan / Research · February 25, 2023

Cutaneous Immune-Related Adverse Events Are Associated With Longer Overall Survival in Patients With Advanced Cancer Receiving ICIs

Journal of the American Academy of Dermatology

 

 Save  Recommend
 Share

Additional Info

Journal of the American Academy of Dermatology
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study
J Am Acad Dermatol 2023 Jan 31;[EPub Ahead of Print], S Zhang, K Tang, G Wan, N Nguyen, C Lu, P Ugwu-Dike, N Raval, J Seo, NA Alexander, R Jairath, J Phillipps, BW Leung, K Roster, W Chen, L Zubiri, G Boland, ST Chen, H Tsao, S Demehri, NR LeBoeuf, KL Reynolds, KH Yu, A Gusev, SG Kwatra, YR Semenov

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated